77 related articles for article (PubMed ID: 15714684)
1. [DIGAMI 2: breaking the spell of insulin for heart infarct. Re the article in DMW 45/2004].
Martin J
Dtsch Med Wochenschr; 2005 Jan; 130(4):175; author reply 175. PubMed ID: 15714684
[No Abstract] [Full Text] [Related]
2. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
Almirall J; Bricullé M; Gonzalez-Clemente JM
Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
[No Abstract] [Full Text] [Related]
3. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
[TBL] [Abstract][Full Text] [Related]
4. The safety of metformin in heart failure.
Roberts F; Ryan GJ
Ann Pharmacother; 2007 Apr; 41(4):642-6. PubMed ID: 17374622
[TBL] [Abstract][Full Text] [Related]
5. [Metformin. Contraindications in heart failure reconsidered].
Schmitt-Hönl B
Med Monatsschr Pharm; 2008 Apr; 31(4):148-9. PubMed ID: 18497248
[No Abstract] [Full Text] [Related]
6. Metformin therapy in patients with type 2 diabetes complicated by heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066
[No Abstract] [Full Text] [Related]
7. A trial in progress: gestational diabetes. Treatment with metformin compared with insulin (the Metformin in Gestational Diabetes [MiG] trial).
Rowan JA;
Diabetes Care; 2007 Jul; 30 Suppl 2():S214-9. PubMed ID: 17596475
[No Abstract] [Full Text] [Related]
8. Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?
Bilous RW
Diabet Med; 2007 Sep; 24(9):931-3. PubMed ID: 17725705
[No Abstract] [Full Text] [Related]
9. Metformin's contraindications should be contraindicated.
McCormack J; Johns K; Tildesley H
CMAJ; 2005 Aug; 173(5):502-4. PubMed ID: 16129871
[No Abstract] [Full Text] [Related]
10. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
[TBL] [Abstract][Full Text] [Related]
11. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
12. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S221-3. PubMed ID: 17055827
[No Abstract] [Full Text] [Related]
13. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
14. Coronary heart disease outcomes in patients receiving antidiabetic agents.
McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
[TBL] [Abstract][Full Text] [Related]
15. [Metformin should not be used by patients with reduced renal function].
Gudmundsdottir H; Brørs O; Os I
Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417
[No Abstract] [Full Text] [Related]
16. Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Stambolic V; Woodgett JR; Fantus IG; Pritchard KI; Goodwin PJ
Breast Cancer Res Treat; 2009 Mar; 114(2):387-9. PubMed ID: 18438706
[No Abstract] [Full Text] [Related]
17. Metformin: an advance in ovulation induction.
Turner MJ; Langan H; Farah N; Byrne K; Cleary B
Ir Med J; 2005 May; 98(5):133-4. PubMed ID: 16010777
[No Abstract] [Full Text] [Related]
18. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
Goodarzi MO; Bryer-Ash M
Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
[TBL] [Abstract][Full Text] [Related]
19. Is metformin safe in patients with mild renal insufficiency?
Kazory A; Walsh K; Harman E; Talor Z
Diabetes Care; 2007 Feb; 30(2):444. PubMed ID: 17259530
[No Abstract] [Full Text] [Related]
20. [Metformin and intravascular contrast media. National guidelines 2001-03-16].
Lakartidningen; 2001 Apr; 98(16):1935-6. PubMed ID: 11370412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
